WATERTOWN, Mass., Oct. 05, 2016 -- A new study among pediatricians shows that they use and recommend the Exergen TemporalScanner over Braun Thermoscan ear thermometers or any other thermometer brand. A full 42 percent of pediatricians personally use the Exergen TAT and 36 percent recommend it to their patients, ranking highest in both categories. In addition, the results show that nearly two-thirds of pediatricians (64.4 percent) who use or recommend Exergen temporal artery thermometers do so for patients of all ages. This pediatrician endorsement provides a powerful reason for consumers to purchase the Exergen TemporalScanner for the entire family.
The study further shows that pediatricians ranked temporal artery thermometry (TAT) number one in overall preference over any other thermometry method, including ear thermometers from Braun. Of the 268 survey respondents, 40.5 percent ranked TAT number one based on overall performance, compared to ear, rectal, oral and axillary thermometry. In addition, more than half (57.3 percent) of pediatricians ranked TAT number one in ease of use. This is particularly important when taking a baby or child’s temperature because it is non-invasive and can even be done while they sleep.
“This study confirms what we’ve known for some time – that the Exergen TemporalScanner is the clear choice among pediatricians, including over Braun ear thermometers. When consumers experience their physicians using the Exergen TemporalScanner temporal artery thermometer, they are motivated to buy the product for their use at home,” said Dr. Francesco Pompei, CEO of Exergen Corporation. "With more than 60 clinical studies supporting its accuracy, physicians have come to trust and rely on the Exergen brand. It is non-invasive, easy to use and accurate, which enhances the physician-patient bond."
The survey was conducted by Pragmatic Research, Inc. and pediatricians were not told that it was sponsored by Exergen. The results were consistent with other independent research involving nurses and other healthcare professionals in various clinical settings.
ABOUT EXERGEN CORPORATION
Exergen Corporation is a recognized world leader in industrial and medical non-invasive temperature technology. The company manufactures and markets TemporalScanner thermometer models for hospitals and clinics, and consumer models sold in major retailers nationwide. Nearly two billion temperatures are taken each year with Exergen TemporalScanners in thousands of hospitals, clinics and pediatricians' offices across the country, as well as in millions of homes. It is the #1 preference of pediatricians, nurses, and mothers and is the #1 selling retail thermometer. The Exergen TemporalScanner’s performance is supported by more than 60 peer-reviewed published studies covering all ages from preterm infants to geriatrics, and all care areas from hospitals to homes. For additional information, visit www.exergen.com.
Contact: Victoria Day Rosica Public Relations [email protected] P: 201.843.5600 F: 201.843.5680 21-00 Route 208 South, Suite 130 Fair Lawn, NJ 07410


Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Britain Courts Anthropic Amid US Defense Department Dispute
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
First Western Ship Transits Strait of Hormuz Since Iran War Began
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk 



